India has largely rejected the trial offer of Sputnik V, the world’s first corona vaccine invented by Russia. According to a report by the British news agency Reuters, the country’s drug regulators are not sure about the effectiveness and safety of the vaccine, rejected a large-scale testing proposal and asked for a short trial.
Dr. of India Reddy’s Laboratory Ltd. wanted to conduct a large-scale clinical trial of the Sputnik-V Kovid-19 vaccine in Russia. According to Indian media, last month, the Russian Direct Investment Fund (RDIF) engaged in the marketing of the Russian vaccine, Dr. Reddy’s Laboratory Ltd. At that time, he also confirmed the supply of 100 million doses of Corona ticker. The matter was raised in an RDIF press release. Now that the regulators have not approved the test, the agreement could be pushed.
Experts at India’s Central Drug Standards Control Organization (CDSCO) say that the safety and effectiveness of the Russian vaccine is limited due to its initial testing on very few volunteers outside India.
Russia is the first country in the world to approve the Corona vaccine. Researchers and clinicians have concerns about its effectiveness and safety as they have approved it before large-scale clinical trials. However, Russian President Vladimir Putin praised his country’s vaccine. One of his daughters was also vaccinated. In a speech to the United Nations General Assembly, he also called for the vaccination of UN officials.